Narrow search
Showing 1 - 10 of 1,141
Cover Image
Implementing accountability for reasonableness : the case of pharmaceutical reimbursement in Sweden
Jansson, Sandra - In: Health economics, policy and law 2 (2007) 2, pp. 153-171
Persistent link: https://www.econbiz.de/10003494815
Cover Image
The impact of pharmaceutical innovation on longevity and medical expenditure in Sweden, 1997-2010 : evidence from longitudinal, disease-level data
Lichtenberg, Frank R.; Pettersson, Billie - 2012
expenditure in Sweden, where mean age at death increased by 1.88 years during the period 1997-2010. Pharmaceutical innovation is … utilization in Sweden, so the cost per life-year gained from the introduction of new drugs was quite low. -- longevity … ; pharmaceutical ; innovation ; drugs ; Sweden …
Persistent link: https://www.econbiz.de/10009571756
Cover Image
The impact of pharmaceutical innovation on longevity and medical expenditure in Sweden, 1997 - 2010 : evidence from longitudinal, disease-level data
Lichtenberg, Frank R.; Pettersson, Billie - In: Economics of innovation and new technology 23 (2014) 3/4, pp. 239-273
Persistent link: https://www.econbiz.de/10010407486
Cover Image
Innovative drugs and the increase in pharmaceutical expenditures
Ekelund, Mats - In: Competition and innovation in the Swedish …, (pp. 1-24). 2001
Persistent link: https://www.econbiz.de/10001602231
Cover Image
Pharmaceutical pricing in a regulated market
Ekelund, Mats; Persson, Björn - In: The review of economics and statistics 85 (2003) 2, pp. 298-306
Persistent link: https://www.econbiz.de/10001762624
Cover Image
The Impact of Pharmaceutical Innovation on Longevity and Medical Expenditure in Sweden, 1997-2010 : Evidence from Longitudinal, Disease-Level Data
Lichtenberg, Frank R.; Pettersson, Billie - 2021
expenditure in Sweden, where mean age at death increased by 1.88 years during the period 1997-2010. Pharmaceutical innovation is … utilization in Sweden, so the cost per life-year gained from the introduction of new drugs was quite low …
Persistent link: https://www.econbiz.de/10013315886
Cover Image
Whose time is it? : understanding clock-time pacing and event-time pacing in complex innovations
Dougherty, Deborah Jane; Bertels, Heidi; Chung, Ken; … - In: Management and organization review : MOR ; the journal … 9 (2013) 2, pp. 233-263
Persistent link: https://www.econbiz.de/10009787998
Cover Image
Innovation and market structure in pharmaceuticals : an econometric analysis on simulated data
Garavaglia, Christian; Malerba, Franco; Orsenigo, Luigi; … - In: Jahrbücher für Nationalökonomie und Statistik 234 (2014) 2/3, pp. 274-298
Persistent link: https://www.econbiz.de/10010344943
Cover Image
Product innovation success based on cancer research in the pharmaceutical industry : co-publication networks and the effects of partners
McKelvey, Maureen D.; Rake, Bastian - In: Industry and innovation 23 (2016) 5, pp. 383-406
Persistent link: https://www.econbiz.de/10011523939
Cover Image
Adverse effects of patent pooling on product development and commercialization
Jeitschko, Thomas D.; Zhang, Nanyun - In: The B.E. journal of theoretical economics 14 (2014) 1, pp. 27-57
Persistent link: https://www.econbiz.de/10010417576